- Home
- ZVSA vs NAOV Comparison
ZVSA vs NAOV Comparison
Compare ZVSA & NAOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZVSA
- NAOV
- Stock Information
- Founded
- ZVSA 2014
- NAOV 2003
- Country
- ZVSA United States
- NAOV United States
- Employees
- ZVSA N/A
- NAOV N/A
- Industry
- ZVSA Biotechnology: Pharmaceutical Preparations
- NAOV Industrial Specialties
- Sector
- ZVSA Health Care
- NAOV Health Care
- Exchange
- ZVSA Nasdaq
- NAOV Nasdaq
- Market Cap
- ZVSA 3.0M
- NAOV 2.4M
- IPO Year
- ZVSA N/A
- NAOV N/A
- Fundamental
- Price
- ZVSA $0.65
- NAOV $0.95
- Analyst Decision
- ZVSA
- NAOV
- Analyst Count
- ZVSA 0
- NAOV 0
- Target Price
- ZVSA N/A
- NAOV N/A
- AVG Volume (30 Days)
- ZVSA 1.4M
- NAOV 8.2M
- Earning Date
- ZVSA 08-08-2025
- NAOV 08-13-2025
- Dividend Yield
- ZVSA N/A
- NAOV N/A
- EPS Growth
- ZVSA N/A
- NAOV N/A
- EPS
- ZVSA N/A
- NAOV N/A
- Revenue
- ZVSA N/A
- NAOV $2,662,000.00
- Revenue This Year
- ZVSA N/A
- NAOV N/A
- Revenue Next Year
- ZVSA N/A
- NAOV N/A
- P/E Ratio
- ZVSA N/A
- NAOV N/A
- Revenue Growth
- ZVSA N/A
- NAOV N/A
- 52 Week Low
- ZVSA $0.47
- NAOV $0.67
- 52 Week High
- ZVSA $6.30
- NAOV $16.25
- Technical
- Relative Strength Index (RSI)
- ZVSA 50.60
- NAOV 38.63
- Support Level
- ZVSA $0.65
- NAOV $0.85
- Resistance Level
- ZVSA $0.73
- NAOV $1.32
- Average True Range (ATR)
- ZVSA 0.06
- NAOV 0.13
- MACD
- ZVSA 0.00
- NAOV 0.11
- Stochastic Oscillator
- ZVSA 36.04
- NAOV 7.94
About ZVSA ZyVersa Therapeutics Inc.
ZyVersa Therapeutics Inc is a clinical-stage biopharmaceutical company leveraging proprietary technologies to develop drugs for patients with chronic renal or inflammatory diseases with high unmet medical needs. The company has two proprietary globally licensed drug development platforms which are Cholesterol Efflux MediatorTM, VAR 200 (2-hydroxypropyl-beta-cyclodextrin) is an injectable drug in clinical development for the treatment of renal diseases. and IC 100 is a monoclonal antibody inflammasome ASC inhibitor in preclinical development for the treatment of inflammatory conditions.
About NAOV NanoVibronix Inc.
NanoVibronix Inc manufactures noninvasive biological response-activating devices that target biofilm prevention, pain therapy, and wound healing and can be administered at home, without the assistance of medical professionals. Its primary products are UroShield; PainShield; and WoundShield. Each of its UroShield, PainShield, and WoundShield products employs a small, disposable transducer that transmits low-frequency, low-intensity ultrasound acoustic waves that seek to repair and regenerate tissue, musculoskeletal and vascular structures, and decrease biofilm formation on urinary catheters and associated urinary tract infections. The company derives revenues from selling its products directly to patients, through distributor agreements.